Financials Bayer S.A. (Peru)

Equities

BAYERI1

PEP726005007

Diversified Chemicals

End-of-day quote Lima 06:00:00 2024-07-02 pm EDT 5-day change 1st Jan Change
20 PEN 0.00% Intraday chart for Bayer S.A. (Peru) 0.00% +41.84%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 206.1 206.1 207.6 207.6 207.6 207.6
Enterprise Value (EV) 1 178.5 174.2 183.2 228.7 264.3 239.7
P/E ratio 5.44 x 8.37 x 5.61 x 10.2 x 7.81 x 17.2 x
Yield - - 173% - - -
Capitalization / Revenue 0.61 x 0.71 x 0.63 x 0.54 x 0.55 x 0.62 x
EV / Revenue 0.53 x 0.6 x 0.56 x 0.6 x 0.7 x 0.71 x
EV / EBITDA 3.78 x 6 x 3.55 x 6.03 x 5.72 x 10.3 x
EV / FCF -89.6 x 23 x -11.7 x 0.7 x -6.84 x 9.78 x
FCF Yield -1.12% 4.35% -8.54% 142% -14.6% 10.2%
Price to Book 0.51 x 0.48 x 0.44 x 1.62 x 1.34 x 1.25 x
Nbr of stocks (in thousands) 14,724 14,724 14,724 14,724 14,724 14,724
Reference price 2 14.00 14.00 14.10 14.10 14.10 14.10
Announcement Date 3/8/19 7/27/20 3/29/21 3/31/22 3/31/23 3/27/24
1PEN in Million2PEN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 338 291.6 327.9 381.4 376.2 337.5
EBITDA 1 47.28 29.04 51.58 37.93 46.21 23.28
EBIT 1 46.07 28.19 50.76 36.77 45.21 21.89
Operating Margin 13.63% 9.67% 15.48% 9.64% 12.02% 6.49%
Earnings before Tax (EBT) 1 53.54 38.15 55.41 35.28 43.96 17.51
Net income 1 37.89 24.63 37 20.26 26.58 12.04
Net margin 11.21% 8.45% 11.28% 5.31% 7.07% 3.57%
EPS 2 2.573 1.673 2.513 1.376 1.805 0.8178
Free Cash Flow 1 -1.991 7.574 -15.65 325.4 -38.62 24.5
FCF margin -0.59% 2.6% -4.77% 85.33% -10.26% 7.26%
FCF Conversion (EBITDA) - 26.08% - 857.97% - 105.23%
FCF Conversion (Net income) - 30.75% - 1,606.54% - 203.47%
Dividend per Share - - 24.45 - - -
Announcement Date 3/8/19 7/27/20 3/29/21 3/31/22 3/31/23 3/27/24
1PEN in Million2PEN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 21.1 56.7 32.1
Net Cash position 1 27.6 31.9 24.4 - - -
Leverage (Debt/EBITDA) - - - 0.556 x 1.227 x 1.379 x
Free Cash Flow 1 -1.99 7.57 -15.7 325 -38.6 24.5
ROE (net income / shareholders' equity) 9.76% 5.89% 8.24% 6.81% 18.8% 7.51%
ROA (Net income/ Total Assets) 6.49% 3.75% 6.23% 5.83% 10.8% 5.05%
Assets 1 584.2 657.4 594.4 347.3 246.9 238.6
Book Value Per Share 2 27.60 29.20 31.80 8.680 10.50 11.30
Cash Flow per Share 2 1.880 2.820 2.010 0.8200 0.9600 0.5600
Capex 1 1.22 1.47 1.13 4.25 1.79 0.79
Capex / Sales 0.36% 0.5% 0.34% 1.11% 0.48% 0.23%
Announcement Date 3/8/19 7/27/20 3/29/21 3/31/22 3/31/23 3/27/24
1PEN in Million2PEN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. BAYERI1 Stock
  4. Financials Bayer S.A. (Peru)